Aurevia (formerly Scandinavian CRO)

Aurevia offers consulting services within medtech regulatory compliance, as well as clinical research CRO services supporting pharmaceuticals, ATMPs, biologics, medical devices, and in vitro diagnostic devices.

Aurevia’s External Quality Assessment Services (EQAS) ensure that clinical laboratories meet the required quality standards. The company was formed in 2025 when Scandinavian CRO, QAdvis, Artimed, Clinical Consulting, Kasve, Labquality, and P.R.I.S.M.A. merged to become Aurevia.

The company’s services for the healthcare, pharmaceutical, and medical technology sectors cover external quality assessments, quality assurance, regulatory affairs, clinical studies, audits and certifications, and training. Their proven expertise and knowledge benefit medical device and in vitro diagnostic (IVD) manufacturers, pharmaceutical companies, healthcare units, and clinical laboratories around the world. Together, they to pave the way for safer, more effective patient care worldwide.